8-K
XBRL
8-K
- Company
- Mereo BioPharma Group plc
- Filed
- August 12, 2025
- Period of Report
- August 12, 2025
- Accession Number
- 0000950170-25-106924
An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →